[Drug combination therapies for patients with hyperlipidemia and its significance].
Onuma
T
T
Department of Internal Medicine, Metabolism and Endocrinology, School of Medicine, Juntendo University.
Kawamori
R
R
D000837:Anion Exchange Resins / Q000627:therapeutic use*; D001629:Bezafibrate / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use
D000837:Anion Exchange Resins; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D001629:Bezafibrate